RBD5044 in Chinese Participants With Hypertriglyceridemia

Clinical trial NCT07587788 · RECRUITING

Trial details

NCT number: NCT07587788
Sponsor: Ribotek Biopharmaceuticals (Shandong) Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2026-02-28
Primary completion: 2027-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.